Patients with Chronic Lymphocyte Leukemia (CLL) Have Naturally Occurring Antibodies Against the Receptor Tyrosine Kinase (ROR1)

被引：0
|
作者：
Hojjat-Farsangi, Mohammad [1 ]
Mozaffari, Fariba [1 ]
Daneshmanesh, Amir Hossein [1 ]
Osterborg, Anders [2 ]
Shokri, Faze [3 ]
Mellstedt, Hakan [4 ]
机构：
[1] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden
[3] Univ Tehran Med Sci, Dept Immunol, Sch Publ Hlth, Tehran, Iran
[4] Karolinska Inst, Karolinska Univ Hosp, Dept Oncol Radiumhemmet & Hematol, Canc Ctr Karolinska, Stockholm, Sweden
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：773 / 773
页数：1
相关论文
共 50 条
  • [21] Localization of disulfide bonds in the frizzled module of Ror1 receptor tyrosine kinase
    Roszmusz, E
    Patthy, A
    Trexler, M
    Patthy, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) : 18485 - 18490
  • [22] Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development
    Development Genes and Evolution, 2001, 211 : 161 - 171
  • [23] Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development
    Al-Shawi, R
    Ashton, SV
    Underwood, C
    Simons, JP
    DEVELOPMENT GENES AND EVOLUTION, 2001, 211 (04) : 161 - 171
  • [24] Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development
    Matsuda, T
    Nomi, M
    Ikeya, M
    Kani, S
    Oishi, I
    Terashima, T
    Tawada, S
    Minami, Y
    MECHANISMS OF DEVELOPMENT, 2001, 105 (1-2) : 153 - 156
  • [25] ROR1 Isoforms Are Constitutively Phosphorylated in Chronic Lympho cytic Leukemia (CLL) - a Survival Factor for CLL Cells
    Mellstedt, Hakan
    Hojjat-Farsangi, Mohammad
    Mansouri, Ladan
    Osterborg, Anders
    Rabbani, Hodjattallah
    BLOOD, 2011, 118 (21) : 775 - 776
  • [26] Overexpression of orphan receptor tyrosine kinase Ror1 as a putative tumor-associated antigen in Iranian patients with acute lymphoblastic leukemia
    Shabani, Mahdi
    Omran, Hossein Asgaria
    Jeddi-Tehrani, Mahmood
    Vossough, Parvaneh
    Faranoush, Mohammad
    Sharifian, Ramazan A.
    Toughe, Gholam R.
    Kordmahin, Mahin
    Khoshnoodi, Jalal
    Roohi, Azam
    Tavoosi, Narjes
    Mellstedt, Hakan
    Rabbani, Hodjatallah
    Shokri, Fazel
    TUMOR BIOLOGY, 2007, 28 (06) : 318 - 326
  • [27] Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies
    Yang, Jiahui
    Baskar, Sivasubramanian
    Kwong, Ka Yin
    Kennedy, Michael G.
    Wiestner, Adrian
    Rader, Christoph
    PLOS ONE, 2011, 6 (06):
  • [28] Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target
    Juho Heliste
    Anne Jokilammi
    Ilkka Paatero
    Deepankar Chakroborty
    Christoffer Stark
    Timo Savunen
    Maria Laaksonen
    Klaus Elenius
    BMC Cardiovascular Disorders, 18
  • [29] SMALL MOLECULES TARGETING ROR1 INDUCE SPECIFIC KILLING OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS
    Moshfegh, A.
    Khan, S.
    Vagberg, J.
    Bystrom, S.
    Hojat-Farsangi, M.
    Mansouri, L.
    Sandin, A.
    Manesh, A. Danesh
    Osterborg, A.
    Mellstedt, H.
    HAEMATOLOGICA, 2012, 97 : 433 - 433
  • [30] Efficient Gene Delivery to Chronic Lymphocytic Leukemia (CLL) Cells with Microbubbles Bearing ROR1 Antibody
    Zhang, Suping
    Cui, Wenjin
    Mattrey, Robert
    Kipps, Thomas J.
    BLOOD, 2011, 118 (21) : 1232 - 1232
12345